Opportunities for Riboswitch Inhibition by Targeting Co-Transcriptional RNA Folding Events.
RNA folding
antibiotics
antisense oligonucleotide
bacteria
drug target
riboswitch
riboswitch inhibitor
transcription
translation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Sep 2024
29 Sep 2024
Historique:
received:
21
08
2024
revised:
27
09
2024
accepted:
27
09
2024
medline:
16
10
2024
pubmed:
16
10
2024
entrez:
16
10
2024
Statut:
epublish
Résumé
Antibiotic resistance is a critical global health concern, causing millions of prolonged bacterial infections every year and straining our healthcare systems. Novel antibiotic strategies are essential to combating this health crisis and bacterial non-coding RNAs are promising targets for new antibiotics. In particular, a class of bacterial non-coding RNAs called riboswitches has attracted significant interest as antibiotic targets. Riboswitches reside in the 5'-untranslated region of an mRNA transcript and tune gene expression levels
Identifiants
pubmed: 39408823
pii: ijms251910495
doi: 10.3390/ijms251910495
pii:
doi:
Substances chimiques
Riboswitch
0
Anti-Bacterial Agents
0
Ligands
0
RNA, Bacterial
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Burroughs Wellcome Fund
ID : 1016945
Organisme : National Institute of Health
ID : 2016389
Organisme : National Science Foundation
ID : DGE-2038238